BUSINESS DEVELOPMENT AND LICENSING
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. Our strategy is to commercialize our products in the United States and to enter into licensing or additional distribution agreements for commercialization of our products outside the United States. As part of our longer-term strategy, we anticipate that we will selectively copromote, in-license or acquire additional products and/or late-stage product candidates that are synergistic with our commercial strategy.
Horizon Pharma has partnered with the following companies:
- Mallinckrodt LLC - U.S. DUEXIS® Copromotion Agreement
- Mundipharma International - EU, Asia and Latin America LODOTRA® Distribution and Supply Agreements
- Grünenthal S.A. - Latin America DUEXIS Collaboration License and Supply Agreement
If you would like to discuss partnership opportunities with Horizon Pharma, please contact:
Vice President, Business Development and Alliance Management
Horizon Pharma, Inc.
520 Lake Cook Road, Suite 520
Deerfield, IL 60015
Last updated August 2, 2012